Benjamin N. Rome

3.9k total citations · 2 hit papers
95 papers, 2.0k citations indexed

About

Benjamin N. Rome is a scholar working on Economics and Econometrics, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Benjamin N. Rome has authored 95 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Economics and Econometrics, 19 papers in Pharmacology and 17 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Benjamin N. Rome's work include Pharmaceutical Economics and Policy (54 papers), Health Systems, Economic Evaluations, Quality of Life (50 papers) and Pharmaceutical industry and healthcare (19 papers). Benjamin N. Rome is often cited by papers focused on Pharmaceutical Economics and Policy (54 papers), Health Systems, Economic Evaluations, Quality of Life (50 papers) and Pharmaceutical industry and healthcare (19 papers). Benjamin N. Rome collaborates with scholars based in United States, New Zealand and Australia. Benjamin N. Rome's co-authors include Aaron S. Kesselheim, Elena Losina, Jeffrey N. Katz, Thomas S. Thornhill, John Wright, Jerry Avorn, William M. Reichmann, Alexander Weinstein, Jamie E. Collins and William B. Feldman and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Benjamin N. Rome

81 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Dramatic Increase in Total Knee Replacement Utilization Rates in the United States Cannot Be Fully Explained by Growth in Population Size and the Obesity Epidemic

2012 405 citations Elena Losina, Thomas S. Thornhill et al. Journal of Bone and Joint Surgery profile →
Estimating the Burden of Total Knee Replacement in the United States

2013 358 citations Alexander Weinstein, Benjamin N. Rome et al. Journal of Bone and Joint Surgery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin N. Rome United States	18	891	544	492	155	138	95	2.0k
Marja Blom Finland	27	562 0.6×	266 0.5×	465 0.9×	131 0.8×	31 0.2×	55	2.2k
Christopher J Edwards United Kingdom	36	664 0.7×	142 0.3×	2.5k 5.1×	188 1.2×	103 0.7×	168	4.3k
J. Fryer Australia	21	791 0.9×	125 0.2×	807 1.6×	271 1.7×	243 1.8×	34	3.3k
Amy S. Mudano United States	25	957 1.1×	89 0.2×	648 1.3×	59 0.4×	224 1.6×	53	2.4k
Sylvain Mathieu France	26	337 0.4×	208 0.4×	1.1k 2.2×	154 1.0×	22 0.2×	92	2.4k
Frank Mehnert Denmark	29	1.3k 1.5×	95 0.2×	237 0.5×	146 0.9×	64 0.5×	54	2.6k
Holly K. Van Houten United States	25	611 0.7×	230 0.4×	92 0.2×	120 0.8×	24 0.2×	75	2.4k
Joseph M. Messana United States	22	335 0.4×	190 0.3×	85 0.2×	74 0.5×	57 0.4×	64	2.2k
M.A.F.J. van de Laar Netherlands	22	386 0.4×	94 0.2×	733 1.5×	161 1.0×	46 0.3×	38	1.5k
Martijn G.H. van Oijen Netherlands	35	1.8k 2.1×	150 0.3×	102 0.2×	53 0.3×	39 0.3×	142	4.2k

Countries citing papers authored by Benjamin N. Rome

Since Specialization

Citations

This map shows the geographic impact of Benjamin N. Rome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin N. Rome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin N. Rome more than expected).

Fields of papers citing papers by Benjamin N. Rome

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin N. Rome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin N. Rome. The network helps show where Benjamin N. Rome may publish in the future.

Co-authorship network of co-authors of Benjamin N. Rome

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin N. Rome. A scholar is included among the top collaborators of Benjamin N. Rome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin N. Rome. Benjamin N. Rome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Christopher, et al.. (2025). Changes in Medicare Part D Plan Designs After the Inflation Reduction Act. JAMA Internal Medicine. 185(10). 1266–1266.

Kim, John, Aaron S. Kesselheim, Edward R. Scheffer Cliff, & Benjamin N. Rome. (2025). Medicare spending and use of subcutaneous biologic formulations with hyaluronidase. The Oncologist. 30(6).

Hwang, Catherine S., Rishi Desai, Aaron S. Kesselheim, et al.. (2025). Health Care Spending After Initiating Sacubitril-Valsartan vs Renin-Angiotensin System Blockers for Heart Failure Treatment. JAMA Health Forum. 6(2). e245385–e245385.

Rome, Benjamin N., et al.. (2025). Academic Detailing Interventions and Evidence-Based Prescribing. JAMA Network Open. 8(1). e2453684–e2453684. 2 indexed citations

Rome, Benjamin N., et al.. (2024). Use, Spending, and Prices of Adalimumab Following Biosimilar Competition. JAMA Health Forum. 5(12). e243964–e243964. 1 indexed citations

Lalani, Hussain S., et al.. (2024). Availability and Cost of Expensive and Common Generic Prescription Drugs: A Cross-sectional Analysis of Direct-to-Consumer Pharmacies. Journal of General Internal Medicine. 39(12). 2187–2195. 3 indexed citations

Davey, Sonya, Massimiliano Russo, Suzanne Davies, et al.. (2024). Changes in Use of Hepatitis C Direct-Acting Antivirals After Access Restrictions Were Eased by State Medicaid Programs. JAMA Health Forum. 5(4). e240302–e240302. 5 indexed citations

Mitchell, Aaron Philip, et al.. (2024). Trends in prices of checkpoint inhibitors in the US, 2016-2023.. Journal of Clinical Oncology. 42(16_suppl). 11075–11075.

Russo, Massimiliano, et al.. (2024). Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition. JAMA Health Forum. 5(3). e235429–e235429. 16 indexed citations

10.

Mitchell, Aaron Philip, et al.. (2024). Overlapping and non-overlapping indications for checkpoint inhibitors in the US.. Journal of Clinical Oncology. 42(16_suppl). 11057–11057. 14 indexed citations

11.

Kesselheim, Aaron S., et al.. (2024). Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications. Pharmacoepidemiology and Drug Safety. 33(10).

12.

Jain, Nina, Benjamin N. Rome, & Mallika L. Mendu. (2024). Misaligned Pharmacy Incentives in Value-Based Care. JAMA. 332(4). 281–281. 1 indexed citations

13.

Rome, Benjamin N. & Aaron S. Kesselheim. (2023). Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups. Arthritis & Rheumatology. 75(8). 1325–1327. 7 indexed citations

14.

Raymakers, Adam, et al.. (2023). Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union. SSRN Electronic Journal.

15.

Bart, Stephen M., Teresa Smith, Sarah Anne J. Guagliardo, et al.. (2023). 2287. Goal! Goal! Goal! Detection of SARS-CoV-2 Variants in Travelers During the FIFA World Cup, Qatar 2022 — CDC Traveler-Based Genomic Surveillance Program, November 2022–January 2023. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

16.

Cliff, Edward R. Scheffer, Aaron S. Kesselheim, Benjamin N. Rome, & William B. Feldman. (2023). Trends in Medicare Spending on Oral Drugs for Chronic Lymphocytic Leukemia From 2014 to 2020. JAMA Network Open. 6(4). e237467–e237467. 1 indexed citations

17.

Rome, Benjamin N., Joshua J. Gagne, Jerry Avorn, & Aaron S. Kesselheim. (2021). Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study. American Heart Journal. 233. 109–121. 28 indexed citations

18.

Losina, Elena, Jamie E. Collins, Meghan E. Daigle, et al.. (2013). The AViKA (Adding Value in Knee Arthroplasty) postoperative care navigation trial: rationale and design features. BMC Musculoskeletal Disorders. 14(1). 290–290. 9 indexed citations

19.

Weinstein, Alexander, Benjamin N. Rome, William M. Reichmann, et al.. (2013). Estimating the Burden of Total Knee Replacement in the United States. Journal of Bone and Joint Surgery. 95(5). 385–392. 358 indexed citations breakdown →

20.

Suter, Lisa G., A. David Paltiel, Benjamin N. Rome, et al.. (2013). Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty. PLoS ONE. 8(5). e62709–e62709. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact